These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19074869)

  • 41. Detection of BRCA1 and BRCA2 mutations in a selected Hawaii population.
    Carney ME; Basiliere MS; Mates K; Sing CK
    Hawaii Med J; 2010 Nov; 69(11):268-71. PubMed ID: 21218378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women.
    Haffty BG; Silber A; Matloff E; Chung J; Lannin D
    J Med Genet; 2006 Feb; 43(2):133-7. PubMed ID: 15983021
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian families with high risk of breast cancer.
    Guénard F; Labrie Y; Ouellette G; Beauparlant CJ; Durocher F;
    J Hum Genet; 2009 Mar; 54(3):152-61. PubMed ID: 19197335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry.
    Cai Q; Wen W; Qu S; Li G; Egan KM; Chen K; Deming SL; Shen H; Shen CY; Gammon MD; Blot WJ; Matsuo K; Haiman CA; Khoo US; Iwasaki M; Santella RM; Zhang L; Fair AM; Hu Z; Wu PE; Signorello LB; Titus-Ernstoff L; Tajima K; Henderson BE; Chan KY; Kasuga Y; Newcomb PA; Zheng H; Cui Y; Wang F; Shieh YL; Iwata H; Le Marchand L; Chan SY; Shrubsole MJ; Trentham-Dietz A; Tsugane S; Garcia-Closas M; Long J; Li C; Shi J; Huang B; Xiang YB; Gao YT; Lu W; Shu XO; Zheng W
    Cancer Res; 2011 Feb; 71(4):1344-55. PubMed ID: 21303983
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer.
    Zhang J; Pei R; Pang Z; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
    Breast Cancer Res Treat; 2012 Apr; 132(2):421-8. PubMed ID: 21614564
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
    Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA
    Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. No association of the TGF-β1 29T/C polymorphism with breast cancer risk in Caucasian and Asian populations: evidence from a meta-analysis involving 55,841 subjects.
    Alqumber MA; Dar SA; Haque S; Wahid M; Singh R; Akhter N
    Asian Pac J Cancer Prev; 2014; 15(20):8725-34. PubMed ID: 25374198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
    Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
    Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of PALB2 sequence variants with the risk of early-onset breast cancer in patients from Turkey.
    Cecener G; Guney Eskiler G; Egeli U; Tunca B; Alemdar A; Gokgoz S; Tasdelen I
    Mol Biol Rep; 2016 Nov; 43(11):1273-1284. PubMed ID: 27573125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.
    Nanda R; Schumm LP; Cummings S; Fackenthal JD; Sveen L; Ademuyiwa F; Cobleigh M; Esserman L; Lindor NM; Neuhausen SL; Olopade OI
    JAMA; 2005 Oct; 294(15):1925-33. PubMed ID: 16234499
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation.
    Wen WX; Soo JS; Kwan PY; Hong E; Khang TF; Mariapun S; Lee CS; Hasan SN; Rajadurai P; Yip CH; Mohd Taib NA; Teo SH
    Breast Cancer Res; 2016 May; 18(1):56. PubMed ID: 27233495
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of LGALS3 gene polymorphisms on susceptibility and prognosis of dilated cardiomyopathy in a Northern Han Chinese population.
    Zhang Y; Wang Y; Zhai M; Gan T; Zhao X; Zhang R; An T; Huang Y; Zhou Q; Zhang J
    Gene; 2018 Feb; 642():293-298. PubMed ID: 29129812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The 811 C/T polymorphism in the 3' untranslated region of the selenoprotein 15-kDa (Sep15) gene and breast cancer in Caucasian women.
    Watrowski R; Castillo-Tong DC; Fabjani G; Schuster E; Fischer M; Zeillinger R
    Tumour Biol; 2016 Jan; 37(1):1009-15. PubMed ID: 26264612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history.
    Malone KE; Daling JR; Thompson JD; O'Brien CA; Francisco LV; Ostrander EA
    JAMA; 1998 Mar; 279(12):922-9. PubMed ID: 9544766
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparative study of Korean with Caucasian breast cancer reveals frequency of methylation in multiple genes correlates with breast cancer in young, ER, PR-negative breast cancer in Korean women.
    Lee JS; Lo PK; Fackler MJ; Argani P; Zhang Z; Garrett-Meyer E; Sukumar S
    Cancer Biol Ther; 2007 Jul; 6(7):1114-20. PubMed ID: 17611401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer.
    Chen W; Pan K; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Lu Y; You W; Xie Y
    Breast Cancer Res Treat; 2009 Sep; 117(1):55-60. PubMed ID: 18512148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families.
    Cherbal F; Bakour R; Adane S; Boualga K; Benais-Pont G; Maillet P
    Dis Markers; 2010; 28(6):377-84. PubMed ID: 20683152
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia.
    Yang XR; Devi BCR; Sung H; Guida J; Mucaki EJ; Xiao Y; Best A; Garland L; Xie Y; Hu N; Rodriguez-Herrera M; Wang C; Jones K; Luo W; Hicks B; Tang TS; Moitra K; Rogan PK; Dean M
    Breast Cancer Res Treat; 2017 Oct; 165(3):687-697. PubMed ID: 28664506
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CHEK2 c.1100delC allele is rarely identified in Greek breast cancer cases.
    Apostolou P; Fostira F; Papamentzelopoulou M; Michelli M; Panopoulos C; Fountzilas G; Konstantopoulou I; Voutsinas GE; Yannoukakos D
    Cancer Genet; 2015 Apr; 208(4):129-34. PubMed ID: 25835597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the need for routine clinical testing of PALB2 c.1592delT mutation in BRCA negative Northern Finnish breast cancer families.
    Haanpää M; Pylkäs K; Moilanen JS; Winqvist R
    BMC Med Genet; 2013 Aug; 14():82. PubMed ID: 23941127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.